Case Fatalities in Hospitalised COVID-19 Patients in the UK

Case Fatalities in Hospitalised COVID-19 Patients in the UK: An ISARIC Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04527458

Enrollment

70000

Registered

2020-08-26

Start date

2020-02-24

Completion date

2020-08-02

Last updated

2020-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

COVID-19, ISARIC, Hospitalisations, Mortality, Case fatality, United Kingdom

Brief summary

This study will investigate how the case fatality in hospitalised patients with COVID-19 has changed throughout the pandemic. It will also explore possible mechanisms that could be driving these changes. This analysis will enhance our understanding of the virus, which will be important for researchers and clinicians to respond appropriately.

Interventions

OTHERPatient Characteristics

Characteristics of the patients

OTHERCOVID-19 treatments

Specific treatments used on COVID-19 patients

OTHERDifferences in triage

Triage criteria for treating COVID-19 patients

OTHERSurge capacity

Capacity of hospitals

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients admitted with a proven or high likelihood of COVID-19

Design outcomes

Primary

Measure	Time frame	Description
Case fatality	23 weeks	The proportion of new admissions with COVID-19 who died over time

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026